E-LIB Suche - Ergebnisse für: Brueckl, Wolfgang

1

Anti-angiogenic agents for NSCLC following first-line immun..:

Reck, Martin ; Popat, Sanjay ; Grohé, Christian...
Lung Cancer. 179 (2023) - p. 107173 , 2023

Link: https://doi.org/10.1016/..

2

P2.03a-060 Favorable Survival of TTF-1 Expression in Pemetr..:

Steppert, Claus ; Leistner, Rumo ; Brueckl, Wolfgang...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S925-S926 , 2017

Link: https://doi.org/10.1016/..

3

TGF-beta receptor 2 downregulation in tumour-associated str..:

Bacman, David ; Merkel, Susanne ; Croner, Roland...
BMC Cancer. 7 (2007) 1 - p. , 2007

Link: https://doi.org/10.1186/..

4

Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligi..:

Griesinger, Frank ; Eberhardt, Wilfried E.E. ; Brueckl, Wolfgang M....
JTO Clinical and Research Reports. 5 (2024) 4 - p. 100626 , 2024

Link: https://doi.org/10.1016/..

5

Response of an HER2-Mutated NSCLC Patient to Trastuzumab De..:

Falk, Markus ; Willing, Eva ; Schmidt, Stefanie...
Current Oncology. 30 (2023) 2 - p. 1692-1698 , 2023

Link: https://doi.org/10.3390/..

6

Older patients with EGFR mutation-positive non-small cell l..:

Brueckl, Wolfgang M. ; Reck, Martin ; Schäfer, Harald...
Journal of Geriatric Oncology. 14 (2023) 1 - p. 101394 , 2023

Link: https://doi.org/10.1016/..

7

Fluctuation of Acquired Resistance Mutations and Re-Challen..:

Falk, Markus ; Schatz, Stefanie ; Reich, Fabian P. M....
Current Oncology. 30 (2023) 10 - p. 8865-8871 , 2023

Link: https://doi.org/10.3390/..

8

The impact of TP53 co-mutations and immunologic microenviro..:

Christopoulos, Petros ; Kluck, Klaus ; Kirchner, Martina...
European Journal of Cancer. 170 (2022) - p. 106-118 , 2022

Link: https://doi.org/10.1016/..

9

Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-..:

Brueckl, Wolfgang M ; Reck, Martin ; Rittmeyer, Achim...
Clinical Medicine Insights: Oncology. 14 (2020) - p. 117955492095135 , 2020

Link: https://doi.org/10.1177/..

10

Clinically relevant prognostic and predictive markers for i..:

Brueckl, Wolfgang M. ; Ficker, Joachim H. ; Zeitler, Gloria
BMC Cancer. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

11

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibi..:

Riedl, Jakob M. ; Barth, Dominik A. ; Brueckl, Wolfgang M....
Cancers. 12 (2020) 8 - p. 2319 , 2020

Link: https://doi.org/10.3390/..

12

Erlotinib treatment after platinum-based therapy in elderly..:

Brueckl, Wolfgang M. ; Achenbach, H. Jost ; Ficker, Joachim H..
BMC Cancer. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

13

Afatinib-associated Stevens-Johnson syndrome in an EGFR-mut..:

Doesch, Janine ; Debus, Dirk ; Meyer, Christian...
Lung Cancer. 95 (2016) - p. 35-38 , 2016

Link: https://doi.org/10.1016/..

14

SNAI2/SLUG and estrogen receptor mRNA expression are invers..:

Atmaca, Akin ; Wirtz, Ralph W ; Werner, Dominique...
BMC Cancer. 15 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

15

Prognostic and predictive value of estrogen receptor 1 expr..:

Brueckl, Wolfgang Michael ; Al-Batran, Salah-Eddin ; Ficker, Joachim Hans...
International Journal of Cancer. 133 (2013) 8 - p. 1825-1831 , 2013

Link: https://doi.org/10.1002/..